These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17239835)

  • 1. Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations?
    Hewitt NJ; de Kanter R; LeCluyse E
    Chem Biol Interact; 2007 May; 168(1):51-65. PubMed ID: 17239835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspective.
    Chu V; Einolf HJ; Evers R; Kumar G; Moore D; Ripp S; Silva J; Sinha V; Sinz M; Skerjanec A
    Drug Metab Dispos; 2009 Jul; 37(7):1339-54. PubMed ID: 19389860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New technologies and screening strategies for hepatotoxicity: use of in vitro models.
    Dambach DM; Andrews BA; Moulin F
    Toxicol Pathol; 2005; 33(1):17-26. PubMed ID: 15805052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for genotoxicity testing--metabolic considerations.
    Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
    Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human and animal hepatocytes in vitro with extrapolation in vivo.
    O'Brien PJ; Chan K; Silber PM
    Chem Biol Interact; 2004 Nov; 150(1):97-114. PubMed ID: 15522264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations.
    Hewitt NJ; Lecluyse EL; Ferguson SS
    Xenobiotica; 2007; 37(10-11):1196-224. PubMed ID: 17968743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process.
    Huang SM; Strong JM; Zhang L; Reynolds KS; Nallani S; Temple R; Abraham S; Habet SA; Baweja RK; Burckart GJ; Chung S; Colangelo P; Frucht D; Green MD; Hepp P; Karnaukhova E; Ko HS; Lee JI; Marroum PJ; Norden JM; Qiu W; Rahman A; Sobel S; Stifano T; Thummel K; Wei XX; Yasuda S; Zheng JH; Zhao H; Lesko LJ
    J Clin Pharmacol; 2008 Jun; 48(6):662-70. PubMed ID: 18378963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of drug interaction studies in drug development: the good, the bad, and the unknown.
    Alfaro CL
    Psychopharmacol Bull; 2001; 35(4):80-93. PubMed ID: 12397858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
    Kanebratt KP; Andersson TB
    Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.
    Bennett CL; Nebeker JR; Yarnold PR; Tigue CC; Dorr DA; McKoy JM; Edwards BJ; Hurdle JF; West DP; Lau DT; Angelotta C; Weitzman SA; Belknap SM; Djulbegovic B; Tallman MS; Kuzel TM; Benson AB; Evens A; Trifilio SM; Courtney DM; Raisch DW
    Arch Intern Med; 2007 May; 167(10):1041-9. PubMed ID: 17533207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.
    Bjornsson TD; Callaghan JT; Einolf HJ; Fischer V; Gan L; Grimm S; Kao J; King SP; Miwa G; Ni L; Kumar G; McLeod J; Obach SR; Roberts S; Roe A; Shah A; Snikeris F; Sullivan JT; Tweedie D; Vega JM; Walsh J; Wrighton SA;
    J Clin Pharmacol; 2003 May; 43(5):443-69. PubMed ID: 12751267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PhRMA survey on the conduct of first-in-human clinical trials under exploratory investigational new drug applications.
    Karara AH; Edeki T; McLeod J; Tonelli AP; Wagner JA
    J Clin Pharmacol; 2010 Apr; 50(4):380-91. PubMed ID: 20097935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human hepatocytes: isolation, cryopreservation and applications in drug development.
    Li AP
    Chem Biol Interact; 2007 May; 168(1):16-29. PubMed ID: 17270162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interactions evaluation: an integrated part of risk assessment of therapeutics.
    Zhang L; Reynolds KS; Zhao P; Huang SM
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):134-45. PubMed ID: 20045016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.